Transcriptional Correlates of Tolerance and Lethality in Mice Predict Ebola Virus Disease Patient Outcomes
Adam Price,
Atsushi Okumura,
Elaine Haddock,
Friederike Feldmann,
Kimberly Meade-White,
Pryanka Sharma,
Methinee Artami,
W. Ian Lipkin,
David W. Threadgill,
Heinz Feldmann,
Angela L. Rasmussen
Affiliations
Adam Price
Center for Infection and Immunity, Columbia Mailman School of Public Health, New York, NY 10032, USA
Atsushi Okumura
Center for Infection and Immunity, Columbia Mailman School of Public Health, New York, NY 10032, USA; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA
Elaine Haddock
Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA
Friederike Feldmann
Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA
Kimberly Meade-White
Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA; Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA
Pryanka Sharma
Center for Infection and Immunity, Columbia Mailman School of Public Health, New York, NY 10032, USA
Methinee Artami
Center for Infection and Immunity, Columbia Mailman School of Public Health, New York, NY 10032, USA
W. Ian Lipkin
Center for Infection and Immunity, Columbia Mailman School of Public Health, New York, NY 10032, USA
David W. Threadgill
Department of Molecular and Cellular Medicine, Texas A&M University Health Science Center, College Station, TX 77843, USA; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA
Heinz Feldmann
Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA
Angela L. Rasmussen
Center for Infection and Immunity, Columbia Mailman School of Public Health, New York, NY 10032, USA; Corresponding author
Summary: Host response to infection is a major determinant of disease severity in Ebola virus disease (EVD), but gene expression programs associated with outcome are poorly characterized. Collaborative Cross (CC) mice develop strain-dependent EVD phenotypes of differential severity, ranging from tolerance to lethality. We screen 10 CC lines and identify clinical, virologic, and transcriptomic features that distinguish tolerant from lethal outcomes. Tolerance is associated with tightly regulated induction of immune and inflammatory responses shortly following infection, as well as reduced inflammatory macrophages and increased antigen-presenting cells, B-1 cells, and γδ T cells. Lethal disease is characterized by suppressed early gene expression and reduced lymphocytes, followed by uncontrolled inflammatory signaling, leading to death. We apply machine learning to predict outcomes with 99% accuracy in mice using transcriptomic profiles. This signature predicts outcomes in a cohort of EVD patients from western Africa with 75% accuracy, demonstrating potential clinical utility. : Using a panel of genetically diverse mice, Price et al. define host responses linked to Ebola virus tolerance and identify distinct gene expression programs underlying pathogenesis. The application of these profiles predicts disease outcomes in mice and human patients. Keywords: Ebola, virus, transcriptomics, pathogenesis, host response, tolerance, Collaborative Cross, classification